The rush memory and aging project: Study design and baseline characteristics of the study cohort

Neuroepidemiology

Volumn 25, Issue 4, 2005, Pages 163-175

  Bennett, David A ^a,b   Schneider, Julie A ^a,b   Buchman, Aron S ^a,b   De Leon, Carlos Mendes ^b,c   Bienias, Julia L ^b,c   Wilson, Robert S ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Clinical pathologic study; Cognitive function; Dementia

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EDUCATION; ETHNOLOGY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEMORY; METHODOLOGY; ORGAN DONOR; PATHOLOGY; RACE; RESIDENTIAL HOME;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AUTOPSY; BRAIN; CHICAGO; COGNITION; COHORT STUDIES; DATA COLLECTION; DNA; EDUCATION; FEMALE; HUMANS; MALE; MEMORY; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; RESEARCH DESIGN; RISK FACTORS;

EID: 27544507775     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087446     Document Type: Article

References (91)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer's disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-1122.
2. Bloom BS, de Pouvourville N, Straus WL: Cost of illness of Alzheimer's disease: how useful are current estimates? Gerontologist 2003;43:158-164.
3. Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337-1342.
4. Sloane PD, Zimmerman S, Suchindran C, et al: The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health 2002;23:213-221.
5. Bennett DA, Wilson RS, Schneider JA, et al: Apolipoprotein E4 allele, Alzheimer's disease pathology, and the clinical expression of AD. Neurology 2003;60:246-252.
6. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Berry-Kravis E, Arnold SE: Amyloid mediates the association of apolipoprotein Eε4 to level of cognitive function in older persons. J Neurol Neurosurg Psychiatry 2005;76:in press.
7. Knopman DS, Parisi JE, Salviati A, et al: Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 2003;62:1087-1095.
8. Morris JC, Storandt M, Miller JP, et al: Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405.
9. Green MS, Kaye JA, Ball MJ: The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old. Neurology 2000;54:105-113.
10. Schmitt FA, Wetherby MM, Wekstein DR, Dearth CM, Markesbery WR: Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. Gerontologist 2001;41:716-722.
11. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA: Cerebral infarctions and the likelihood of dementia from Alzheimer's disease pathology. Neurology 2004;62:1148-1155.
12. Bennett DA, Wilson RS, Schneider JA, et al: Education modifies the relation of AD pathology to cognitive function in older persons. Neurology 2003;60:1909-1915.
13. Bennett DA, Wilson RS, Schneider JA, Bienias JL, Arnold SE: Cerebral infarctions and the relation of depressive symptoms to level of cognitive function in older persons. Am J Geriatr Psychiatry 2004;12:211-219.
14. Wilson RS, Evans DA, Bienias JL, Mendes de Leon CF, Schneider JA, and Bennett DA: Proneness to psychological distress and risk of Alzheimer's disease. Neurology 2003;61:1579-1585.
15. Katzman R, Terry R, DeTeresa R, et al: Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988;23:138-441.
16. Scarmeas N, Stern Y: Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep 2004;4:374-380.
17. Staff RT, Murray AD, Deary IJ, Whalley LJ: What provides cerebral reserve? Brain 2004;127:1191-1199.
18. Lindsted KD, Fraser GE, Steinkohl M, Beeson WL: Healthy volunteer effect in a cohort study: temporal resolution in the Adventist Health Study. J Clin Epidemiol 1996;49:783-790.
19. McKhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan E: Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939.
20. Bennett DA, Wilson RS, Schneider JA, et al: Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
21. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS: Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005;64:834-841.
22. Adams HP Jr, Bendixen BH, Kappelle LJ, et al: Subtypes of acute ischemic stroke definitions for multi-center clinical trials. Stroke 1993;24:35-41.
23. Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: Diagnostic criteria for research studies - Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
24. Langston JW, Widner H, Goetz CGT, et al: Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992;7:2-13.
25. McKeith IG, Perry EK, Perry RH: Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 1999;53:902-905.
26. Robins LN, Helzer JE, Ratcliff KS, Seyfried W: Validity of the Diagnostic Interview Schedule. II. DSM-III diagnoses. Psychol Med 1982;12:855-870.
27. Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA: Parkinsonian-like signs and risk of incident Alzheimer's disease in older persons. Arch Neurol 2003;60:539-544.
28. Wilson RS, Schneider JA, Bienias JL, Arnold S, Evans DA, Bennett DA: Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology 2003;61:1102-1108.
29. Harik-Khan, RI, Wise RA, Fozard JL: Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med 1998;158:1459-1464.
30. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State': A practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
31. Wechsler D: Wechsler Memory Scale-Revised Manual. New York, Psychological Corporation, 1987.
32. Albert MS, Smith LA, Scherr PA, et al: Use of brief cognitive tests to identify individuals in the community with clinically-diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-178.
33. Wilson RS, Beckett LA, Barnes LL, et al: Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-193.
34. Morris J, Heyman A, Mohs, R, et al: The consortium to establish a registry for Alzheimer's disease (CERAD). Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
35. Kaplan EF, Goodglass H, Weintraub S: The Boston Naming Test. Philadelphia, Lea & Febiger, 1983.
36. Cooper JA, Sagar HJ: Incidental and intentional recall in Parkinson's disease: An account based on diminished attentional resources. J Clin Exp Neuropsychol 1993;15:713-731.
37. Smith A: Symbol Digit Modalities Test manual-revised. Los Angeles, Western Psychological, 1984.
38. Ekstrom RB, French JW, Harman HH, Dermen D: Manual for the kit of factor-referenced cognitive tests. Princeton, Educational Testing Service, 1976.
39. Trenerry MR, Crosson B, DeBoe J, Leber WR: The Stroop Neuropsychological Screening Test. Odessa, Psychological Assessment Resources, 1989.
40. Benton AL, Varney N, et al: Visuospatial judgment - A clinical test. Arch Neurol 1978;35:364-367.
41. Raven JC, Court JH, Raven J: Standard progressive matrices. Raven Manual, sect 3. Oxford, Oxford Psychologists Press, 1992.
42. Goodglass H, Kaplan E: The Assessment of Aphasia and Related Disorders. Philadelphia, Lea & Febiger, 1972.
43. Wilson RS, Barnes LL, Kreuger KR, Hoganson G, Bienias JL, Bennett DA: Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc, in press.
44. Fleischman DA, Wilson RS, Bienias JL, Bennett DA: Parkinsonian signs and cognitive function in old age. J Int Neuropsychol Soc, in press.
45. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS: Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology 1997;49:1580-1587.
46. Bennett DA, Shannon KM, Beckett LA, Wilson RS: Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J Gerontol Med Sci 1999;54:M191-M196.
47. Wilson RS, Bienias JL, Mendes de Leon CF, Evans DA, Bennett DA: Negative affect and mortality in older persons. Am J Epidemiol 2003;158:827-835.
48. Tiffin J, Asher EJ: The Purdue Pegboard: Norms and studies of reliability and validity. J Appl Psychol 1948;32:234-247.
49. Buchman AS, Wilson RS, Bienias JL, Bennett DA: Gender differences in motor performance of older persons. Geriatr Gerontol Int 2005;5:59-65.
50. Wang CY, Olson SL, Protas EJ: Test-retest strength reliability: hand-held dynamometry in community-dwelling elderly fallers. Arch Phys Med Rehabil 2002;83:811-815.
51. Katz S, Akpom C: A measure of primary sociobiological functions. Int J Health Serv 1976;6:493-508.
52. Rosow I, Breslau N: A Guttman health scale for the aged. J Gerontol 1966;21:556-559.
53. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
54. Tinetti ME, Ginter SF: The nursing home life-space diameter: a measure of extent and frequency of mobility among nursing home residents. J Am Geriatric Soc 1990;38:1311-1315.
55. Stalvey BT, Owsley C, Sloane ME, Ball K: The Life Space Questionnaire: A measure of the extent of mobility of older adults. J Appl Gerontol 1999;18:460-478.
56. van Praag H, Kempermann G, Gage FH: Neural consequences of environmental enrichment. Nat Rev Neurosci 2000;1:191-198.
57. Kramer AF, Bherer L, Colcombe SJ, Dong W, Greenough WT: Environmental influences on cognitive and brain plasticity during aging. J Gerontol A Biol Sci Med Sci 2004;59:M940-M957.
58. Lazarov O, Robinson J, Tang YP, et al: Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005;120:701-713.
59. Adlard PA, Perreau VM, Pop V, Cotman CW: Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 2005;25:4217-4221.
60. Wilson RS, Scherr PA, Hoganson G, Bienias JL, Evans DA, Bennett DA: Early life socioeconomic status and late life risk of Alzheimer's disease. Neuroepidemiology 2005;25:8-14.
61. Richardson MT, Leon AS, Jacobs DR Jr, Ainsworth BE, Serfass R: Comprehensive evaluation of the Minnesota Leisure Time Physical Activity Questionnaire. J Clin Epidemiol 1994;47:271-281.
62. Wilson RS, Mendes de Leon CF, Barnes LL, Schneider JA, Bienias JL, Evans DA, Bennett DA: Participation in cognitively stimulating activities and risk of AD. JAMA 2002;287:742-748.
63. Mendes de Leon CF, Glass TA, Beckett LA, et al: Social networks and disability transitions across eight intervals of yearly data in the New Haven EPESE. J Gerontol Soc Sci 1999;54:162-172.
64. Mendes de Leon CF, Glass TA, Berkman LF: Social engagement and disability in a community population of older adults: the New Haven EPESE. Am J Epidemiol 2003;157:633-642.
65. de Jong Gierveld J, Kamphuis FH: The development of a Rasch-type loneliness scale. Appl Psychol Meas 1985;9:289-299.
66. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J: Two shorter forms of the CES-D depression symptoms index. J Aging Health 1993;5:179-193.
67. Radloff LS: The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
68. Costa PT, McCrae RR: Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) professional manual. Odessa, Psychological Assessment Resources, 1992.
69. Ryff CD, Keyes CLM: The structure of psychological well-being revisited. J Personal Soc Psychol 1995;69:719-727.
70. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA: Cerebral infarctions and the likelihood of dementia from Alzheimer's disease pathology. Neurology 2004;62:1148-1155.
71. Schneider JA, Bienias J, Gilley DW, Kvarnberg D, Mufson EJ, Bennett DA: Improved detection of neurofibrillary pathology in Alzheimer's disease. J Histochem Cytochem 2002;50:99-106.
72. Falke E, Nissanov J, Mitchell TW, Bennett DA, Trojanowski JQ, Arnold SE: Subicular dendritic arborization is decreased in Alzheimer's disease and correlates with neurofibrillary tangle density. Am J Pathol 2003;163:1615-1621.
73. Honer WG: Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals. Neurobiol Aging 2003;24:1047-1062.
74. Wilson RS, Bennett DA, Bienias JL, et al: Cognitive activity and incident AD in a population-based sample of older persons. Neurology 2002;59:1910-1915.
75. Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H: Walking and dementia in physically capable elderly men. JAMA 2004;292:1447-1453.
76. Verghese J, Lipton RB, Katz MJ, et al: Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003;348:2508-2516.
77. Scarmeas N, Levy G, Tang MX, Manly J, Stern Y: Influence of leisure activity on the incidence of Alzheimer's disease. Neurology 2001;57:2236-2242.
78. Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F: Physical activity, including walking, and cognitive function in older women. JAMA 2004;292:1454-1461.
79. Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K: A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med 2001;161:1703-1708.
80. Podewils LJ, Guallar E, Kuller LH, et al: Physical activity, APOE genotype, and dementia risk: findings from the cardiovascular health cognition study. Am J Epidemiol 2005;161:639-651.
81. Sayer AA, Syddall HE, Gilbody HJ, Dennison EM, Cooper C: Does sarcopenia originate in early life? Findings from the Hertfordshire cohort study. J Gerontol A Biol Sci Med Sci 2004;59:M930-M934.
82. Gill TM, Allore H, Guo Z: The deleterious effects of bed rest among community-living older persons. J Gerontol A Biol Sci Med Sci 2004;59:755-761.
83. Seguin R, Nelson ME: The benefits of strength training for older adults. Am J Prev Med 2003;25(3 suppl 2):141-149.
84. Petrovitch H, White LR, Ross GW, et al: Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology 2001;57:226-234.
85. Troncoso JC, Martin LJ, Dal Forno G, Kawas CH: Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol Aging 1996;17:365-371.
86. Lim A, Tsuang D, Kukull W, et al: Cliniconeuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc 1999;47:564-569.
87. Massoud F, Devi G, Stern Y, et al: A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol 1999;56:1368-1373.
88. Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR: Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA 1996;275:528-532.
89. Mortimer JA, Snowdon DA, Markesbery WR: Head circumference, education and risk of dementia: findings from the Nun Study. J Clin Exp Neuropsychol 2003;25:671-679.
90. Wilson RS, Bienias JL, Evans DA, Bennett DA: The Religious Orders Study: Overview and relation between change in cognitive and motor speed. Aging Neuropsychol Cog 2004;11:280-303.
91. Mortimer JA, Gosche KM, Riley KP, Markesbery WR, Snowdon DA: Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study. Neurology 2004;62:428-432.